The results demonstrated that the expression level of CD19 remained consistent with the public database, and its expression was significantly higher in the ARDS group, suggesting that the data from the public databases were reliable and that CD19 might serve as a potential biomarker. Here, CD19 is linked to acute respiratory distress syndrome.